Smith & Nephew (NYSE:SNN) Shares Gap Down – Here’s Why

Shares of Smith & Nephew plc (NYSE:SNN) gapped down before the market opened on Friday . The stock had previously closed at $29.50, but opened at $28.27. Smith & Nephew shares last traded at $28.20, with a volume of 372,680 shares.

Analyst Upgrades and Downgrades

SNN has been the topic of a number of research reports. StockNews.com upgraded shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research note on Monday, August 5th. Deutsche Bank Aktiengesellschaft assumed coverage on Smith & Nephew in a research report on Wednesday, July 24th. They issued a “buy” rating on the stock. One analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy”.

Smith & Nephew Stock Down 3.8 %

The stock has a fifty day moving average price of $30.30 and a two-hundred day moving average price of $27.68. The company has a market cap of $12.40 billion, a price-to-earnings ratio of 13.77, a P/E/G ratio of 1.29 and a beta of 0.82. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63.

Institutional Trading of Smith & Nephew

Several hedge funds and other institutional investors have recently bought and sold shares of SNN. Argonautica Private Wealth Management Inc. increased its holdings in shares of Smith & Nephew by 6.3% during the second quarter. Argonautica Private Wealth Management Inc. now owns 10,244 shares of the medical equipment provider’s stock worth $254,000 after purchasing an additional 605 shares during the period. First Trust Direct Indexing L.P. increased its stake in Smith & Nephew by 6.9% during the 3rd quarter. First Trust Direct Indexing L.P. now owns 9,659 shares of the medical equipment provider’s stock worth $301,000 after acquiring an additional 626 shares during the period. Inspire Advisors LLC raised its holdings in Smith & Nephew by 3.0% in the 2nd quarter. Inspire Advisors LLC now owns 22,286 shares of the medical equipment provider’s stock valued at $552,000 after acquiring an additional 639 shares in the last quarter. Rhumbline Advisers raised its holdings in Smith & Nephew by 8.6% in the 2nd quarter. Rhumbline Advisers now owns 10,365 shares of the medical equipment provider’s stock valued at $257,000 after acquiring an additional 819 shares in the last quarter. Finally, Legacy Wealth Asset Management LLC grew its holdings in shares of Smith & Nephew by 6.0% during the 1st quarter. Legacy Wealth Asset Management LLC now owns 16,022 shares of the medical equipment provider’s stock worth $406,000 after purchasing an additional 903 shares in the last quarter. Institutional investors and hedge funds own 25.64% of the company’s stock.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.